Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Brain Research Bulletin
|
January 1, 1997
Effects of nicergoline on age-related decrements in radial maze performance and acetylcholine levels
R A McArthur, N Carfagna, L Banfi, et al.
Neuroscience Letters
|
September 15, 1995
Modulation of hippocampal ACh release by chronic nicergoline treatment in freely moving young and aged rats
N Carfagna, A Di Clemente, S Cavanus, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1991
FCE 23884, substrate-dependent interaction with the dopaminergic system. I. Preclinical behavioral studies
M Buonamici, S Mantegani, M A Cervini, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1991
FCE 23884, substrate-dependent interaction with the dopaminergic system. II. Preclinical biochemical studies
N Carfagna, C Caccia, S Mantegani, et al.
Biological Psychiatry
|
May 17, 2000
Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
E H Wong, M S Sonders, S G Amara, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Brain Research Bulletin
|
January 1, 1997
Effects of nicergoline on age-related decrements in radial maze performance and acetylcholine levels
R A McArthur, N Carfagna, L Banfi, et al.
Neuroscience Letters
|
September 15, 1995
Modulation of hippocampal ACh release by chronic nicergoline treatment in freely moving young and aged rats
N Carfagna, A Di Clemente, S Cavanus, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1991
FCE 23884, substrate-dependent interaction with the dopaminergic system. I. Preclinical behavioral studies
M Buonamici, S Mantegani, M A Cervini, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1991
FCE 23884, substrate-dependent interaction with the dopaminergic system. II. Preclinical biochemical studies
N Carfagna, C Caccia, S Mantegani, et al.
Biological Psychiatry
|
May 17, 2000
Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
E H Wong, M S Sonders, S G Amara, et al.
Page
of 2